Horowitz: Study of young boys after vax shows cataclysmic prevalence of heart problems, blows open sudden death theory
What will it take for Republicans to stand united and call for the end of these shots, the investigation of their creation and distribution, and compensation for those injured? Do they really fear the vacuous pejorative of “anti-vaxxer” more than they love a generation of children?
In January, CDC researchers conceded in JAMA that the over 50,000 reported cases of myocarditis and pericarditis in VAERS are “likely” underreported. If they are willing to concede that point, it should be abundantly clear to thinking people that the number of diagnosed cases of myocarditis, and certainly those reported to VAERS, were likely the tip of the iceberg due to the prevalence of subclinical myocarditis. A new preprint study from Thai researchers confirms those suspicions in spectacular fashion with sickening ramifications.
The researchers conducted in-depth cardio health surveillance of 301 adolescent children (13-18 years old), 202 of whom were boys, before they got jabbed and followed them for up to 14 days after the second dose of Pfizer. The findings were mind-blowing. Seven of the 202 boys (3.5%) developed clinical or subclinical myocarditis/ pericarditis! This is not 1 in 5,000 or 1 in 10,000 as we were led to believe, which was bad enough. This equals 1 in 28 of all teenage boys jabbed! Oh, and remember, Moderna has been proven to be even worse for heart inflammation, likely because it is three times the dose of Pfizer.
Keep in mind that these numbers are just for 13- to 18-year-olds, but males around that age and a little older are also in the target zone for myocarditis. There are roughly 21 million boys ages 10-19. There are another 11 million ages 20-24. This means that if the bad guys got their way, there’d be roughly 1.1 million boys and young men with myocarditis of some sort! And we know the risk exists for other ages and for women, just at a lower rate.
Even for the clinical myocarditis, three developed pericarditis or myocarditis and two were hospitalized. That is a cataclysmic level of heart damage, which, if proven true, would certainly explain the anomalous excess cardiac deaths, sudden deaths among young people, and increase in EMS emergency home calls.
More broadly, 18% had abnormal ECGs, and “cardiovascular effects were found in 29.24% of patients, ranging from tachycardia, palpitation, and myopericarditis.”
Now, this doesn’t definitely prove that such a whopping percentage of people incurred heart damage from the shot just based on these markers, but it does demonstrate that subclinical myocarditis affecting an enormous number of people is a real concern at this point. It would also make sense why it appears that elite athletes suffered more severely early on because their level of exertion will bring out that latent heart inflammation much more suddenly than someone with a more sedentary lifestyle.
Before anyone dismisses this as a random preprint, the numbers harmonize perfectly with concerns expressed by the FDA BEFORE it authorized the Comirnaty shot. According the Pfizer informed consent document (p. 5), the company recognized the risk of myocarditis can be as high as 1 in 1,000. But the FDA was concerned that subclinical myocarditis might be even more of a problem.
In the Pharmacovigilance Plan Review Addendum for Comirnaty, the FDA conceded (p. 3-4), “Incidence of subclinical myocarditis and potential long-term sequelae following COMIRNATY are unknown.” However, they did note that a previous study on a smallpox vaccine “suggested an incidence of possible subclinical myocarditis (based on cardiac troponin T elevations) 60-times higher than the incidence rate of overt clinical myocarditis.”
Sixty times greater! If you do the math, that equals 1 in 17 individuals for the highest-risk group, aka young men and teenage boys. They asked Pfizer to complete a study on subclinical myocarditis, but it won’t be completed for another year, long after they pressured and sometimes mandated any teenage boy to get the shot if he wants to join the military, go to college or medical school, or compete in sports. There are still schools in America requiring children to get this dangerous shot. Meanwhile, Denmark won’t even make the shots available for children any more.
Consider that there are 51,000 cases of myocarditis or pericarditis reported to VAERS, which we already know is woefully underreported even for clinical-level illness. If subclinical myocarditis is 60 times greater, that would encompass more than 3 million people.
How has the government allowed this to be approved, much less mandated and continued long after the safety signals were glaring and blaring, without conducting cardiac MRIs on these boys on autopsies on those who die suddenly? One of the ways our government is violating the Nuremberg Code is by not warning people to check for subclinical myocarditis before it’s too late. That requires a cardiac MRI, which is very expensive and won’t be covered by insurance. Rather than funding the latest escapade in Ukraine, our government has an obligation to fund cardiac MRIs for those who got the shots, especially those most at risk for myocarditis. Why are government officials scared to randomly sample the first 5,000 people they find to undergo a cardiac MRI? They sure don’t lack the funds.
Dr. Kirk Milhoan, a pediatric cardiologist and former flight surgeon in the Air Force, tells CR that the heart issues were obvious from early on, given the toxicity of the spike protein, which is why this should never have been given to an entire population, even if it had efficacy against the virus. “We give known cardio-toxins for those with difficult-to-treat cancers that are not amenable to less toxic chemotherapeutic agents. We should never give such an agent to healthy children and adults, whose risk of hospitalization and death is much less than 1%.”
Milhoan cites a new study touted by the American Heart Association demonstrating that the spike protein is cardio-toxic. “This has been clear clinically, and now the cellular mechanism has been identified. No one should be given a cardio-toxic therapeutic for the SarsCov-2 infection. Even more, we should not be asking the body to be making the cardio-toxic protein via DNA or mRNA injectable products.”
The public has been convinced to credulously believe a dastardly lie that somehow there is a substantial risk of myocarditis from natural infection, even more so than from the vaccine. Let’s put aside the fact that these shots do not work to stop such infection anyway. The data simply does not bear this out. A Danish study of 74,611 children found 0 diagnosed with myocarditis in the two months following a COVID infection, compared to a 1/2,700 rate in adolescent boys following two doses of Pfizer. Now, obviously, this study only measured diagnosed cases, not nearly as thorough a physical workup as conducted by the smaller Thai study, but it clearly shows that in an apples-to-apples comparison, the risk for myocarditis from the shots is exponentially higher than the risk from the virus.
In fact, it’s not clear altogether that there is a risk of myocarditis from the virus above the background rate at all for those who don’t suffer critical illness, which is nearly every teenager. A recent Israeli retrospective cohort study of 197,000 patients within the Israeli Clalit Health Services Organization concluded based on the incidence of myocarditis and pericarditis in the system from March 2020 to January 2021 (pre-vaccine COVID era) that the incidence of myocarditis and pericarditis in COVID-infected patients was not increased relative to uninfected, matched controls.
“There is not yet definitive EMB/autopsy proof that SARS-CoV-2 causes direct cardiomyocyte damage in association with histological myocarditis,” wrote the Israeli researchers in the Journal of Clinical Medicine. “Post COVID-19 infection was not associated with either myocarditis (aHR 1.08; 95% CI 0.45 to 2.56) or pericarditis (aHR 0.53; 95% CI 0.25 to 1.13). We did not observe an increased incidence of neither pericarditis nor myocarditis in adult patients recovering from COVID-19 infection.”